Insights
We write about real problems; messy data, reporting that doesn't work, and AI tools that actually earn their place in production. Practitioner perspective, no filler.
AI & Automation
Every executive conversation about AI eventually lands here: should we build something custom or buy a platform? The honest answer is that most companies should start by buying. Off-the-shelf tools cover a surprising amount of ground. They handle generic tasks well. If your problem fits neatly into one of those categories, building custom is a waste of money. But there is a specific moment when buying stops working.
Off-the-shelf tools break down when the value depends on proprietary context that no vendor can access. Your internal taxonomy. Your compliance rules. The way your team actually names things versus what the field labels say. An internal copilot earns its cost when it can pull from three internal systems simultaneously, apply your organization's specific business rules, or generate outputs in the exact format your downstream process requires.
The mistake is treating "build" as an enterprise software project. Internal copilots do not need a React frontend or a six-month roadmap. The ones that actually ship are typically a Python script connected to an LLM API with retrieval over your actual data, deployed behind a simple interface your team already uses. A senior data scientist can prototype a useful internal copilot in two to three weeks.
Ask three questions. Does the value come from general language capability or from proprietary context? Can you describe the exact workflow it would accelerate? Will fewer than fifty people use it? If you answer proprietary context, yes, and yes. You probably have a build case. Everything else, start with a vendor tool. The companies that get the most from AI are not the ones with the biggest budgets. They are the ones that correctly identify which problems are theirs alone.
Healthcare
If you work in healthcare and someone tells you they do analytics, ask them what data they clean first. The answer will tell you everything about whether they have actually done this work. Healthcare analytics in a conference slide deck means predictive models and AI-driven clinical decision support. But in practice, it means spending the first three weeks reconciling member eligibility files that do not agree with claims data and explaining why last quarter’s numbers look different depending on which system you pull from.
In healthcare, the raw material is almost always claims data, eligibility files, provider rosters, and clinical records that were never designed to be analyzed together. Before anyone builds a dashboard or trains a model, someone has to resolve member identity across systems, decide how to handle late-arriving claims, reconcile enrollment files, and normalize provider specialties across taxonomies that change annually. This is not preliminary work. This is the work.
The healthcare analytics projects that deliver measurable value tend to be narrower than people expect: automating a monthly regulatory report that takes an analyst two full weeks, building a reliable member attribution model so operations stops arguing about panels, or creating a single source of truth for utilization metrics so finance and clinical ops work from the same numbers. None of these are glamorous. All of them eliminate real cost.
Machine learning has legitimate applications in healthcare. Risk stratification, readmission prediction, fraud detection. But the prerequisite is always clean, reconciled, well-governed data. The right sequence is: fix the data pipeline, automate the reporting, prove the numbers are trustworthy, then layer in predictive capability. If your analytics team spends more time reconciling data than analyzing it, that is not an analytics failure. That is a data engineering problem disguised as one.
Data & Reporting
Regulatory reporting sounds like it should have been automated years ago. The formats are defined. The deadlines are fixed. The calculations are documented. And yet, someone is still spending the last week of every month manually pulling data from three systems, pasting it into a formatted workbook, and hoping the numbers reconcile before the submission deadline. The reason this persists is not that automation is impossible. It is that the realistic version looks different from what most people imagine.
When executives hear automate regulatory reporting, they picture pushing a button and getting a finished submission. That is the wrong mental model for regulated environments. Regulatory reports carry legal liability. Someone with domain expertise needs to review the output and sign off. The realistic goal is to remove the manual data compilation and formatting that consumes eighty percent of the time, so people can spend that time on review and exception handling instead.
The parts that respond well to automation are predictable: data extraction into a staging layer with consistent schemas, transformation logic that turns raw data into reportable metrics, formatting into the exact structure the regulator requires, reconciliation checks that catch discrepancies before a human sees the output, and audit trails logging every data point back to its source.
For a typical mid-market regulatory report: two weeks to map the manual process end to end, two weeks to build the data pipeline, two weeks to implement calculation logic and output formatting, and two weeks to parallel-run against the manual process. Total: two months. Outcome: a process that took five to ten days of analyst time now takes one day of review. Every month you do not automate a recurring report, you pay the same labor cost again. That is not a technology problem. It is a compounding operational cost with a known fix.
We're available now. Tell us what's going on and we'll tell you honestly whether we can help.